[1]郭徽灵,胡世平,汤发强,等.血管生成素-2在大鼠骨肉瘤细胞中的表达及调控的研究[J].福建医药杂志,2021,43(02):135-138.
　GUO Huiling,HU Shiping,TANG Faqiang,et al.Study on the expression and regulation of angiopoietin-2 in rat osteosarcoma cells[J].FUJIAN MEDICAL JOURNAL,2021,43(02):135-138.
点击复制

血管生成素-2在大鼠骨肉瘤细胞中的表达及调控的研究()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
43
期数:
2021年02期
页码:
135-138
栏目:
基础研究
出版日期:
2021-04-15

文章信息/Info

Title:
Study on the expression and regulation of angiopoietin-2 in rat osteosarcoma cells
文章编号:
1002-2600(2021)02-0135-04
作者:
郭徽灵; 胡世平; 汤发强; 吴 宏; 郑建章
福建医科大学省立临床医学院 福建省立医院骨一科(福州 350001)
Author(s):
GUO Huiling;  HU Shiping;  TANG Faqiang;  WU Hong;  ZHENG Jianzhang
The first Department of Orthopaedics,Fujian Provincial Hospital,Provincial Clinical Medical College of Fujian Medical University,Fuzhou,Fujian 350001,China
关键词:
血管生成素-2;  骨肉瘤;  大鼠模型;  细胞调控
Keywords:
angiopoietin-2;  osteosarcoma;  rat model;  cell regulation
分类号:
R738.1
文献标志码:
A
摘要:
目的 观察血管生成素-2(Ang-2)在大鼠骨肉瘤建模中不同时期的表达及其对骨肉瘤细胞的调控作用。方法 20只大鼠股骨下段注射MG63骨肉瘤细胞,成瘤后分为5、10、15、20 d组,5只股骨下段注射等量生理盐水的大鼠为对照组。测定各组大鼠血清Ang-2含量,并对成瘤行免疫组化染色证实。构建敲减Ang-2基因表达的shRNA慢病毒载体,转染至培养的MG63骨肉瘤细胞中,观察对骨肉瘤细胞周期及凋亡的影响。结果 实验组血清Ang-2在4个不同阶段均较对照组明显升高,其中10 d组上升幅度最大(P值均<0.05); 免疫组化染色发现,成瘤10 d组Ang-2表达阳性细胞数最高,且与血清测定结果相符; 抑制Ang-2表达使骨肉瘤细胞分裂阻滞在G1期,并增加细胞凋亡(P<0.05)。结论 Ang-2与骨肉瘤发生发展关系密切,可能成为骨肉瘤早期诊断及潜在治疗的一个新的参考指标。
Abstract:
Objective To observe the expression of angiogenin-2(Ang-2)at different stages in rat osteosarcoma modeling and its regulation effect on osteosarcoma cells. Methods MG63 osteosarcoma cells were injected into the lower femoral segment of 20 rats,and after tumor formation, the rats were divided into 5, 10, 15, and 20 days groups. Five rats were injected with the same amount of normal saline in the lower femoral segment as the control group.The serum Ang-2 content in each group was determined and confirmed by immunohistochemical staining.ShRNA lentivirus vector with ang-2 gene knockdown was constructed and transfected into cultured MG63 osteosarcoma cells to observe the effects on cell cycle and apoptosis of osteosarcoma cells. Results The serum Ang-2 level in the experimental group was significantly higher than that in the control group at four different stages, with the maximum increase in the 10-days group(all P<0.05).Immunohistochemical staining showed that the number of positive ang-2 cells was the highest in the 10-days tumorigenicity group, which was consistent with the serum test results.Inhibition of Ang-2 expression blocked cell division in the G1 phase and increased apoptosis(P<0.05). Conclusion Ang-2 is closely related to the occurrence and development of osteosarcoma,and may become a new reference index for early diagnosis and potential treatment of osteosarcoma.

参考文献/References:

[1] Friebele J C, Peck J, Pan X, et al.Osteosarcoma: a meta-analysis and review of the literature[J].Am J Orthop, 2015, 44(12):547-553.
[2] Yang J, Zhang W.New molecular insights into osteosarcoma targeted therapy[J].Curr Opin Oncol,2013,25(4): 398-406.
[3] Mirabello L, Troisi R J, Savage S A.International osteosarco-ma incidence patterns in children and adolescents,middle age and elderly persons[J]. Int J Cancer, 2009,125(1):229-234.
[4] Murphey M D.World health organization classification of bone and soft tissue tumors:modifications and implications for radiologists[J]. Semin Musculoskelet Radiol, 2007, 11(3):201-214.
[5] Cho W H, Song W S, Jeon D G, et al.Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations[J]. Ann Surg Oncol, 2010,17(3):702-708.
[6] Limmahakhun S, Pothacharoen P, Theera-Umpon N, et al.Relationships between serum biomarker levels and clinical presentation of human osteosarcomas[J]. Asian Pac J Cancer Prev, 2011, 12(7):1717-1722.
[7] 刘源源, 王生伟.非小细胞肺癌患者血清中VEGF和Ang-2的表达和临床意义[J]. 现代肿瘤医学, 2015,23(19):2774-2777.
[8] Bajpai J, Sharma M, Sreenivas V, et al.VEGF expression as a prognostic marker in osteosarcoma[J]. Pediatr Blood Cancer, 2018,53(6):1035-1039.
[9] 符策岗, 赵红卫, 刘扬, 等.骨肉瘤动物模型新进展[J]. 中国实验动物学报, 2015,23(2):216-220.
[10] Anderson M E.Update on survival in osteosarcoma[J]. Orthop Clin North Am, 2016, 47(1):283-292.
[11] Wang L H, Tsai H C, Cheng Y C, et al.CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin-2 signaling[J]. Cancer Lett, 2017, 391:28-37.
[12] Tsutsui S, Inoue H, Yasuda K, et al.Angiopoietin-2 expres-sion in invasive ductal carcinoma of the osteosarcoma: Its relationship to the VEGF expression and microvessel density[J]. Breast Cancer Res Treat, 2018,98(3):261-266.

相似文献/References:

[1]黄立明 高 曦.LncRNA TUSC7对人骨肉瘤细胞增殖和迁移的影响[J].福建医药杂志,2019,41(01):121.
[2]陈冬冬 林佳生 严 伟 张 韬.基于多重信号放大的miR-135b电化学传感器的制备及效果评价[J].福建医药杂志,2019,41(05):125.
[3]严 伟 陈冬冬 陈 嵘.便携式血糖仪联合血管内皮生长因子适配体传感系统的构建及其在骨肉瘤诊断中的应用[J].福建医药杂志,2020,42(02):33.
　YAN Wei,CHEN Dongdong,CHEN Rong..Construction on sensing system of portable blood glucose meter combined with osteosarcoma protein marker aptamer and its application in diagnosis of osteosarcoma[J].FUJIAN MEDICAL JOURNAL,2020,42(02):33.
[4]刘楠楠 伍林招 张 韬.白花蛇舌草抗骨肉瘤的有效部位筛选及对Bcl-2和Bax细胞因子表达的影响[J].福建医药杂志,2020,42(03):119.
[5]吴冬枝,何文慧,张 韬.基于DNA纳米枝构建可视化比色传感器用于骨肉瘤相关miRNA检测[J].福建医药杂志,2021,43(02):138.
[6]陈冬冬,陈嵘.microRNA-365对骨肉瘤大鼠巨噬细胞增殖和凋亡的影响[J].福建医药杂志,2022,44(02):116.
　CHEN Dongdong,CHEN Rong.Effect of microRNA-365 on macrophage proliferation and apoptosis in osteosarcoma rats[J].FUJIAN MEDICAL JOURNAL,2022,44(02):116.
[7]何文慧,吴冬枝,张韬,等.生姜囊泡包载金纳米粒子的构建及用于骨肉瘤治疗的实验研究[J].福建医药杂志,2023,45(03):118.
[8]李业森.特异性靶向高转移骨肉瘤的长循环型PET探针的合成及显像[J].福建医药杂志,2023,45(06):127.
　LI Yesen.Synthesis and imaging of long-circulating PET probes specifically targeting highly metastatic osteosarcoma[J].FUJIAN MEDICAL JOURNAL,2023,45(02):127.

备注/Memo

备注/Memo:
基金项目:2018年省卫生计生青年科研课题资助项目(2018-1-6)
更新日期/Last Update: 2021-04-15